IL220513A - A cutaneous smear preparation that includes and uses calipotriol - Google Patents

A cutaneous smear preparation that includes and uses calipotriol

Info

Publication number
IL220513A
IL220513A IL220513A IL22051312A IL220513A IL 220513 A IL220513 A IL 220513A IL 220513 A IL220513 A IL 220513A IL 22051312 A IL22051312 A IL 22051312A IL 220513 A IL220513 A IL 220513A
Authority
IL
Israel
Prior art keywords
calcipotriol
composition
cutaneous application
cutaneous
application
Prior art date
Application number
IL220513A
Other languages
English (en)
Hebrew (he)
Other versions
IL220513A0 (en
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL220513A0 publication Critical patent/IL220513A0/en
Publication of IL220513A publication Critical patent/IL220513A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL220513A 2009-12-22 2012-06-19 A cutaneous smear preparation that includes and uses calipotriol IL220513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (en) 2009-12-22 2009-12-22 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Publications (2)

Publication Number Publication Date
IL220513A0 IL220513A0 (en) 2012-08-30
IL220513A true IL220513A (en) 2016-05-31

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220513A IL220513A (en) 2009-12-22 2012-06-19 A cutaneous smear preparation that includes and uses calipotriol

Country Status (13)

Country Link
EP (1) EP2515912A4 (pt)
JP (1) JP5548275B2 (pt)
CN (1) CN102770143B (pt)
AU (1) AU2009357263B2 (pt)
BR (1) BR112012015447A2 (pt)
CA (1) CA2785249A1 (pt)
HK (1) HK1177695A1 (pt)
IL (1) IL220513A (pt)
MX (1) MX2012007227A (pt)
NZ (1) NZ601002A (pt)
RU (1) RU2500387C1 (pt)
WO (1) WO2011076206A1 (pt)
ZA (1) ZA201204619B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106344589B (zh) * 2016-11-10 2019-11-26 江苏知原药业有限公司 一种稳定性改善的卡泊三醇倍他米松组合物
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
US20230225970A1 (en) * 2020-08-26 2023-07-20 Canadian Nano Pharmaceutical Technology Inc. Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
CN115350151B (zh) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 一种高稳定性阿法骨化醇液体口服制剂及其制备方法
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
JP3340310B2 (ja) * 1996-03-28 2002-11-05 株式会社資生堂 複合エマルジョンおよびその製造方法
US6432422B1 (en) * 1997-12-09 2002-08-13 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
CA2312060A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PT1178960E (pt) * 1999-04-23 2004-03-31 Leo Pharma As Analogos da vitamina d e sua utilizacao farmaceutica
JP2001025359A (ja) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp Ｏ／ｗ／ｏ型エマルジョン組成物およびその製造方法
EP1901709A2 (en) * 2005-06-10 2008-03-26 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
WO2006138056A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
FR2893847B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
JP4913487B2 (ja) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 使用感に特徴のある化粧料
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2911781B1 (fr) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid

Also Published As

Publication number Publication date
CN102770143B (zh) 2014-11-05
ZA201204619B (en) 2013-09-25
AU2009357263A1 (en) 2012-07-19
CN102770143A (zh) 2012-11-07
NZ601002A (en) 2014-09-26
HK1177695A1 (en) 2013-08-30
RU2500387C1 (ru) 2013-12-10
AU2009357263B2 (en) 2015-04-09
EP2515912A1 (en) 2012-10-31
WO2011076206A1 (en) 2011-06-30
IL220513A0 (en) 2012-08-30
EP2515912A4 (en) 2013-12-25
JP2013515017A (ja) 2013-05-02
JP5548275B2 (ja) 2014-07-16
BR112012015447A2 (pt) 2016-03-15
MX2012007227A (es) 2012-07-30
CA2785249A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
HUE059796T2 (hu) PSMA-t célzó vegyületek és alkalmazásaik
PL2435503T3 (pl) Emulsje na bazie związków hydroksylowych niosących grupy silylowe
PL2652025T3 (pl) Kompozycja powlekająca i jej zastosowanie
PL3480273T3 (pl) Kompozycje klejowe i ich zastosowanie
EP2412789A4 (en) LUBRICANT COMPOSITION AND ITS USE
EP2563130A4 (en) PESTICIDE COMPOSITION AND ITS USE
EP2511333A4 (en) RUBBER COMPOSITION AND USES THEREOF
IL220513A (en) A cutaneous smear preparation that includes and uses calipotriol
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
EP2501697A4 (en) BENZOIMIDAZOLE COMPOUNDS AND THEIR USES
EP2402429A4 (en) EQUOL-PRODUCING BACTERIUM AND ITS USE
EP2563131A4 (en) PESTICIDAL COMPOSITION AND USE THEREOF
PL2521445T3 (pl) Preparat i jego zastosowanie
GB0902429D0 (en) Compositions and their use
GB0908174D0 (en) Steroid containing composition and uses thereof
EP2410017A4 (en) COMPOSITION AND ELEMENT USING THE SAME
GB0902173D0 (en) Compounds and their use
GB0909768D0 (en) Novel compounds and uses thereof
EP2615094A4 (en) SESTERTERPEN COMPOUNDS AND THEIR USE
GB0922510D0 (en) Compound and use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
SI2246181T1 (sl) Kompozitni material in njegova uporaba
GB2461611B (en) Composition and use thereof
EP2488179A4 (en) NRF2 HEMMER AND ITS USE
GB0909792D0 (en) Composition and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees